Jia Dai

813 total citations
20 papers, 703 citations indexed

About

Jia Dai is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Jia Dai has authored 20 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 9 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Jia Dai's work include Cardiac Fibrosis and Remodeling (10 papers), Signaling Pathways in Disease (5 papers) and NF-κB Signaling Pathways (3 papers). Jia Dai is often cited by papers focused on Cardiac Fibrosis and Remodeling (10 papers), Signaling Pathways in Disease (5 papers) and NF-κB Signaling Pathways (3 papers). Jia Dai collaborates with scholars based in China and Japan. Jia Dai's co-authors include Zhou‐Yan Bian, Qizhu Tang, Heng Zhou, Jing Zong, Wei Deng, Yuan Yuan, Zhen‐Guo Ma, Qi‐Zhu Tang, Hai‐Han Liao and Hongliang Li and has published in prestigious journals such as PLoS ONE, Hypertension and British Journal of Pharmacology.

In The Last Decade

Jia Dai

20 papers receiving 696 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jia Dai 346 235 102 93 86 20 703
Farhan Rizvi 366 1.1× 165 0.7× 56 0.5× 88 0.9× 40 0.5× 34 884
Wenliang Zha 388 1.1× 227 1.0× 87 0.9× 57 0.6× 66 0.8× 20 899
Xue Dong 509 1.5× 149 0.6× 140 1.4× 48 0.5× 105 1.2× 47 994
Li-Mien Chen 328 0.9× 100 0.4× 117 1.1× 54 0.6× 77 0.9× 22 685
Ya‐Ge Jin 306 0.9× 176 0.7× 65 0.6× 44 0.5× 72 0.8× 18 613
Huifeng Hao 354 1.0× 95 0.4× 141 1.4× 129 1.4× 56 0.7× 35 863
Pei Zhao 315 0.9× 145 0.6× 47 0.5× 45 0.5× 62 0.7× 38 594
Minglu Liang 441 1.3× 104 0.4× 185 1.8× 58 0.6× 64 0.7× 52 884

Countries citing papers authored by Jia Dai

Since Specialization
Citations

This map shows the geographic impact of Jia Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia Dai more than expected).

Fields of papers citing papers by Jia Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jia Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia Dai. The network helps show where Jia Dai may publish in the future.

Co-authorship network of co-authors of Jia Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Jia Dai. A scholar is included among the top collaborators of Jia Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jia Dai. Jia Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wen, Juan, et al.. (2019). DHT deteriorates the progression of monocrotaline-induced pulmonary arterial hypertension: effects of endogenous and exogenous androgen.. PubMed. 11(9). 5752–5763. 4 indexed citations
2.
Ma, Zhen‐Guo, Jia Dai, Yu‐Pei Yuan, et al.. (2018). T-bet deficiency attenuates cardiac remodelling in rats. Basic Research in Cardiology. 113(3). 19–19. 54 indexed citations
3.
4.
Ma, Zhen‐Guo, Jia Dai, Wenying Wei, et al.. (2016). Asiatic Acid Protects against Cardiac Hypertrophy through Activating AMPKα Signalling Pathway. International Journal of Biological Sciences. 12(7). 861–871. 60 indexed citations
5.
Ma, Zhen‐Guo, Jia Dai, Wenbin Zhang, et al.. (2016). Protection against cardiac hypertrophy by geniposide involves the GLP‐1 receptor / AMPKα signalling pathway. British Journal of Pharmacology. 173(9). 1502–1516. 97 indexed citations
6.
7.
Yuan, Yuan, Jia Dai, Heng Zhou, et al.. (2015). IRAK4 deficiency promotes cardiac remodeling induced by pressure overload.. PubMed. 8(11). 20434–43. 2 indexed citations
8.
Zhou, Heng, Haipeng Guo, Jing Zong, et al.. (2014). ATF3 regulates multiple targets and may play a dual role in cardiac hypertrophy and injury. International Journal of Cardiology. 174(3). 838–839. 26 indexed citations
9.
Zhou, Heng, Yuan Yuan, Yuan Liu, et al.. (2014). Icariin attenuates angiotensin II-induced hypertrophy and apoptosis in H9c2 cardiomyocytes by inhibiting reactive oxygen species-dependent JNK and p38 pathways. Experimental and Therapeutic Medicine. 7(5). 1116–1122. 34 indexed citations
10.
Yang, Zheng, Yuan Liu, Wei Deng, et al.. (2014). Hesperetin attenuates mitochondria-dependent apoptosis in lipopolysaccharide-induced H9C2 cardiomyocytes. Molecular Medicine Reports. 9(5). 1941–1946. 38 indexed citations
11.
Yuan, Yuan, Jing Zong, Heng Zhou, et al.. (2013). Puerarin attenuates pressure overload-induced cardiac hypertrophy. Journal of Cardiology. 63(1). 73–81. 68 indexed citations
12.
Zong, Jing, Mohamed Salim, Heng Zhou, et al.. (2013). NOD2 deletion promotes cardiac hypertrophy and fibrosis induced by pressure overload. Laboratory Investigation. 93(10). 1128–1136. 34 indexed citations
13.
Zhou, Heng, Yuan Yuan, Wei Deng, et al.. (2013). Paeoniflorin attenuates pressure overload-induced cardiac remodeling via inhibition of TGFβ/Smads and NF-κB pathways. Journal of Molecular Histology. 44(3). 357–367. 44 indexed citations
14.
Zong, Jing, Wei Deng, Heng Zhou, et al.. (2013). 3,3′-Diindolylmethane Protects against Cardiac Hypertrophy via 5′-Adenosine Monophosphate-Activated Protein Kinase-α2. PLoS ONE. 8(1). e53427–e53427. 21 indexed citations
15.
Dai, Jia, Zhi‐Gang She, Zhou‐Yan Bian, et al.. (2013). IKKi Deficiency Promotes Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis. PLoS ONE. 8(1). e53412–e53412. 19 indexed citations
16.
Bian, Zhou‐Yan, Jia Dai, Hiroyasu Nakano, et al.. (2013). Disruption of Tumor Necrosis Factor Receptor Associated Factor 5 Exacerbates Pressure Overload Cardiac Hypertrophy and Fibrosis. Journal of Cellular Biochemistry. 115(2). 349–358. 25 indexed citations
17.
Zong, Jing, Qingqing Wu, Heng Zhou, et al.. (2012). 3,3′-Diindolylmethane attenuates cardiac H9c2 cell hypertrophy through 5′-adenosine monophosphate-activated protein kinase-α. Molecular Medicine Reports. 12(1). 1247–1252. 14 indexed citations
18.
Zong, Jing, Heng Zhou, Zhou-Yan Bian, et al.. (2012). Baicalein protects against cardiac hypertrophy through blocking MEK‐ERK1/2 signaling. Journal of Cellular Biochemistry. 114(5). 1058–1065. 43 indexed citations
19.
Zhou, Heng, Zhou‐Yan Bian, Jing Zong, et al.. (2012). Stem Cell Antigen 1 Protects Against Cardiac Hypertrophy and Fibrosis After Pressure Overload. Hypertension. 60(3). 802–809. 30 indexed citations
20.
Guo, Haipeng, Heng Zhou, Jing Zong, et al.. (2011). Gastrodin protects against cardiac hypertrophy and fibrosis. Molecular and Cellular Biochemistry. 359(1-2). 9–16. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Farhan Rizvi Breakdown of academic impact, for papers by Wenliang Zha Breakdown of academic impact, for papers by Xue Dong Breakdown of academic impact, for papers by Li-Mien Chen Breakdown of academic impact, for papers by Ya‐Ge Jin Breakdown of academic impact, for papers by Huifeng Hao Breakdown of academic impact, for papers by Pei Zhao Breakdown of academic impact, for papers by Minglu Liang
Rankless by CCL
2026